nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—OPRK1—Progesterone—uterine cancer	0.491	0.618	CbGbCtD
Hydrocodone—CYP2D6—Progesterone—uterine cancer	0.0898	0.113	CbGbCtD
Hydrocodone—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0862	0.108	CbGbCtD
Hydrocodone—CYP3A4—Progesterone—uterine cancer	0.0571	0.0718	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—uterine cancer	0.0274	0.0345	CbGbCtD
Hydrocodone—CYP3A4—Etoposide—uterine cancer	0.0256	0.0321	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—uterine cancer	0.0174	0.0219	CbGbCtD
Hydrocodone—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00922	CcSEcCtD
Hydrocodone—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00922	CcSEcCtD
Hydrocodone—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.0089	CcSEcCtD
Hydrocodone—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.00182	0.00887	CcSEcCtD
Hydrocodone—Abdominal discomfort—Progesterone—uterine cancer	0.00176	0.00856	CcSEcCtD
Hydrocodone—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00852	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Progesterone—uterine cancer	0.0017	0.0083	CcSEcCtD
Hydrocodone—Drowsiness—Progesterone—uterine cancer	0.00163	0.00796	CcSEcCtD
Hydrocodone—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00776	CcSEcCtD
Hydrocodone—Urinary tract infection—Progesterone—uterine cancer	0.00159	0.00774	CcSEcCtD
Hydrocodone—Body temperature increased—Carboplatin—uterine cancer	0.00157	0.00764	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00752	CcSEcCtD
Hydrocodone—Lethargy—Dactinomycin—uterine cancer	0.00153	0.00745	CcSEcCtD
Hydrocodone—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00722	CcSEcCtD
Hydrocodone—Oedema peripheral—Progesterone—uterine cancer	0.00144	0.00704	CcSEcCtD
Hydrocodone—Connective tissue disorder—Progesterone—uterine cancer	0.00144	0.00703	CcSEcCtD
Hydrocodone—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00701	CcSEcCtD
Hydrocodone—Angiopathy—Progesterone—uterine cancer	0.00133	0.00649	CcSEcCtD
Hydrocodone—Mediastinal disorder—Progesterone—uterine cancer	0.00132	0.00644	CcSEcCtD
Hydrocodone—Oedema peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00638	CcSEcCtD
Hydrocodone—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00637	CcSEcCtD
Hydrocodone—Mental disorder—Progesterone—uterine cancer	0.00129	0.00626	CcSEcCtD
Hydrocodone—Malnutrition—Progesterone—uterine cancer	0.00128	0.00622	CcSEcCtD
Hydrocodone—Back pain—Progesterone—uterine cancer	0.00124	0.00602	CcSEcCtD
Hydrocodone—Muscle spasms—Progesterone—uterine cancer	0.00123	0.00598	CcSEcCtD
Hydrocodone—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00588	CcSEcCtD
Hydrocodone—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00584	CcSEcCtD
Hydrocodone—Tremor—Progesterone—uterine cancer	0.0012	0.00583	CcSEcCtD
Hydrocodone—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00568	CcSEcCtD
Hydrocodone—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00564	CcSEcCtD
Hydrocodone—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00545	CcSEcCtD
Hydrocodone—Cough—Progesterone—uterine cancer	0.00111	0.00543	CcSEcCtD
Hydrocodone—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00542	CcSEcCtD
Hydrocodone—Convulsion—Progesterone—uterine cancer	0.00111	0.00539	CcSEcCtD
Hydrocodone—Arthralgia—Progesterone—uterine cancer	0.00109	0.0053	CcSEcCtD
Hydrocodone—Myalgia—Progesterone—uterine cancer	0.00109	0.0053	CcSEcCtD
Hydrocodone—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00528	CcSEcCtD
Hydrocodone—Anxiety—Progesterone—uterine cancer	0.00108	0.00528	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00108	0.00526	CcSEcCtD
Hydrocodone—Agranulocytosis—Dactinomycin—uterine cancer	0.00108	0.00525	CcSEcCtD
Hydrocodone—Dry mouth—Progesterone—uterine cancer	0.00106	0.00518	CcSEcCtD
Hydrocodone—Nervous system disorder—Progesterone—uterine cancer	0.00102	0.00498	CcSEcCtD
Hydrocodone—Skin disorder—Progesterone—uterine cancer	0.00101	0.00493	CcSEcCtD
Hydrocodone—Hyperhidrosis—Progesterone—uterine cancer	0.00101	0.00491	CcSEcCtD
Hydrocodone—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00489	CcSEcCtD
Hydrocodone—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000985	0.0048	CcSEcCtD
Hydrocodone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000985	0.0048	CcSEcCtD
Hydrocodone—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000982	0.00478	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000978	0.00477	CcSEcCtD
Hydrocodone—Hypotension—Progesterone—uterine cancer	0.000974	0.00475	CcSEcCtD
Hydrocodone—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000963	0.0047	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000949	0.00463	CcSEcCtD
Hydrocodone—Insomnia—Progesterone—uterine cancer	0.000943	0.00459	CcSEcCtD
Hydrocodone—Paraesthesia—Progesterone—uterine cancer	0.000936	0.00456	CcSEcCtD
Hydrocodone—Dyspnoea—Progesterone—uterine cancer	0.000929	0.00453	CcSEcCtD
Hydrocodone—Somnolence—Progesterone—uterine cancer	0.000926	0.00452	CcSEcCtD
Hydrocodone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000926	0.00451	CcSEcCtD
Hydrocodone—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000925	0.00451	CcSEcCtD
Hydrocodone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000917	0.00447	CcSEcCtD
Hydrocodone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.00445	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Progesterone—uterine cancer	0.0009	0.00438	CcSEcCtD
Hydrocodone—Fatigue—Progesterone—uterine cancer	0.000898	0.00438	CcSEcCtD
Hydrocodone—Constipation—Progesterone—uterine cancer	0.000891	0.00434	CcSEcCtD
Hydrocodone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000882	0.0043	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00086	0.00419	CcSEcCtD
Hydrocodone—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000854	0.00416	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Progesterone—uterine cancer	0.000852	0.00415	CcSEcCtD
Hydrocodone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.00413	CcSEcCtD
Hydrocodone—Neck pain—Epirubicin—uterine cancer	0.000848	0.00413	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Epirubicin—uterine cancer	0.000848	0.00413	CcSEcCtD
Hydrocodone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000842	0.0041	CcSEcCtD
Hydrocodone—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000839	0.00409	CcSEcCtD
Hydrocodone—Abdominal pain—Progesterone—uterine cancer	0.000824	0.00402	CcSEcCtD
Hydrocodone—Body temperature increased—Progesterone—uterine cancer	0.000824	0.00402	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000815	0.00397	CcSEcCtD
Hydrocodone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000814	0.00397	CcSEcCtD
Hydrocodone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000808	0.00394	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Doxorubicin—uterine cancer	0.000784	0.00382	CcSEcCtD
Hydrocodone—Neck pain—Doxorubicin—uterine cancer	0.000784	0.00382	CcSEcCtD
Hydrocodone—Agranulocytosis—Etoposide—uterine cancer	0.00078	0.0038	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000772	0.00376	CcSEcCtD
Hydrocodone—Myalgia—Dactinomycin—uterine cancer	0.000768	0.00374	CcSEcCtD
Hydrocodone—Hypersensitivity—Progesterone—uterine cancer	0.000768	0.00374	CcSEcCtD
Hydrocodone—Asthenia—Progesterone—uterine cancer	0.000748	0.00364	CcSEcCtD
Hydrocodone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00364	CcSEcCtD
Hydrocodone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00364	CcSEcCtD
Hydrocodone—Pruritus—Progesterone—uterine cancer	0.000737	0.00359	CcSEcCtD
Hydrocodone—Thrombocytopenia—Dactinomycin—uterine cancer	0.000721	0.00351	CcSEcCtD
Hydrocodone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000696	0.00339	CcSEcCtD
Hydrocodone—Dizziness—Progesterone—uterine cancer	0.000689	0.00336	CcSEcCtD
Hydrocodone—Angiopathy—Etoposide—uterine cancer	0.000681	0.00332	CcSEcCtD
Hydrocodone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000678	0.0033	CcSEcCtD
Hydrocodone—Mediastinal disorder—Etoposide—uterine cancer	0.000676	0.0033	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000671	0.00327	CcSEcCtD
Hydrocodone—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00326	CcSEcCtD
Hydrocodone—Vomiting—Progesterone—uterine cancer	0.000663	0.00323	CcSEcCtD
Hydrocodone—Rash—Progesterone—uterine cancer	0.000657	0.0032	CcSEcCtD
Hydrocodone—Dermatitis—Progesterone—uterine cancer	0.000656	0.0032	CcSEcCtD
Hydrocodone—Headache—Progesterone—uterine cancer	0.000653	0.00318	CcSEcCtD
Hydrocodone—Hot flush—Epirubicin—uterine cancer	0.00065	0.00317	CcSEcCtD
Hydrocodone—Menopausal symptoms—Epirubicin—uterine cancer	0.000644	0.00314	CcSEcCtD
Hydrocodone—Fatigue—Dactinomycin—uterine cancer	0.000635	0.0031	CcSEcCtD
Hydrocodone—Back pain—Etoposide—uterine cancer	0.000632	0.00308	CcSEcCtD
Hydrocodone—Muscle spasms—Etoposide—uterine cancer	0.000628	0.00306	CcSEcCtD
Hydrocodone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000624	0.00304	CcSEcCtD
Hydrocodone—Lethargy—Epirubicin—uterine cancer	0.00062	0.00302	CcSEcCtD
Hydrocodone—Nausea—Progesterone—uterine cancer	0.000619	0.00302	CcSEcCtD
Hydrocodone—Osteoarthritis—Epirubicin—uterine cancer	0.000608	0.00296	CcSEcCtD
Hydrocodone—Pain in extremity—Epirubicin—uterine cancer	0.000608	0.00296	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000602	0.00294	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—uterine cancer	0.000601	0.00293	CcSEcCtD
Hydrocodone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0006	0.00293	CcSEcCtD
Hydrocodone—Affect lability—Epirubicin—uterine cancer	0.000598	0.00292	CcSEcCtD
Hydrocodone—Migraine—Epirubicin—uterine cancer	0.000598	0.00292	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—uterine cancer	0.000596	0.00291	CcSEcCtD
Hydrocodone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000595	0.0029	CcSEcCtD
Hydrocodone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000595	0.0029	CcSEcCtD
Hydrocodone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000592	0.00288	CcSEcCtD
Hydrocodone—Abdominal pain—Dactinomycin—uterine cancer	0.000582	0.00284	CcSEcCtD
Hydrocodone—Body temperature increased—Dactinomycin—uterine cancer	0.000582	0.00284	CcSEcCtD
Hydrocodone—Mood swings—Epirubicin—uterine cancer	0.000576	0.00281	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—uterine cancer	0.000574	0.0028	CcSEcCtD
Hydrocodone—Cough—Etoposide—uterine cancer	0.00057	0.00278	CcSEcCtD
Hydrocodone—Convulsion—Etoposide—uterine cancer	0.000566	0.00276	CcSEcCtD
Hydrocodone—Dehydration—Epirubicin—uterine cancer	0.000565	0.00276	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—uterine cancer	0.000563	0.00274	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—uterine cancer	0.000563	0.00274	CcSEcCtD
Hydrocodone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000561	0.00273	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—uterine cancer	0.000554	0.0027	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—uterine cancer	0.000554	0.0027	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—uterine cancer	0.000553	0.0027	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000552	0.00269	CcSEcCtD
Hydrocodone—Hypersensitivity—Dactinomycin—uterine cancer	0.000543	0.00264	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—uterine cancer	0.000533	0.0026	CcSEcCtD
Hydrocodone—Asthenia—Dactinomycin—uterine cancer	0.000528	0.00258	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—uterine cancer	0.000523	0.00255	CcSEcCtD
Hydrocodone—Thrombocytopenia—Etoposide—uterine cancer	0.000522	0.00254	CcSEcCtD
Hydrocodone—Skin disorder—Etoposide—uterine cancer	0.000518	0.00252	CcSEcCtD
Hydrocodone—Hyperhidrosis—Etoposide—uterine cancer	0.000515	0.00251	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—uterine cancer	0.000512	0.0025	CcSEcCtD
Hydrocodone—Hypotension—Etoposide—uterine cancer	0.000498	0.00243	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000488	0.00238	CcSEcCtD
Hydrocodone—Paraesthesia—Etoposide—uterine cancer	0.000479	0.00233	CcSEcCtD
Hydrocodone—Dyspnoea—Etoposide—uterine cancer	0.000475	0.00232	CcSEcCtD
Hydrocodone—Somnolence—Etoposide—uterine cancer	0.000474	0.00231	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—uterine cancer	0.000469	0.00228	CcSEcCtD
Hydrocodone—Vomiting—Dactinomycin—uterine cancer	0.000468	0.00228	CcSEcCtD
Hydrocodone—Rash—Dactinomycin—uterine cancer	0.000464	0.00226	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Etoposide—uterine cancer	0.00046	0.00224	CcSEcCtD
Hydrocodone—Fatigue—Etoposide—uterine cancer	0.00046	0.00224	CcSEcCtD
Hydrocodone—Constipation—Etoposide—uterine cancer	0.000456	0.00222	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—uterine cancer	0.000455	0.00222	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000452	0.0022	CcSEcCtD
Hydrocodone—Nausea—Dactinomycin—uterine cancer	0.000438	0.00213	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—uterine cancer	0.000437	0.00213	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Etoposide—uterine cancer	0.000436	0.00212	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—uterine cancer	0.000434	0.00211	CcSEcCtD
Hydrocodone—Abdominal pain—Etoposide—uterine cancer	0.000421	0.00205	CcSEcCtD
Hydrocodone—Body temperature increased—Etoposide—uterine cancer	0.000421	0.00205	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—uterine cancer	0.000421	0.00205	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—uterine cancer	0.000414	0.00202	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—uterine cancer	0.000413	0.00201	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—uterine cancer	0.000405	0.00197	CcSEcCtD
Hydrocodone—Hypersensitivity—Etoposide—uterine cancer	0.000393	0.00191	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—uterine cancer	0.000383	0.00187	CcSEcCtD
Hydrocodone—Asthenia—Etoposide—uterine cancer	0.000382	0.00186	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000382	0.00186	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—uterine cancer	0.000382	0.00186	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—uterine cancer	0.000379	0.00185	CcSEcCtD
Hydrocodone—Pruritus—Etoposide—uterine cancer	0.000377	0.00184	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—uterine cancer	0.000368	0.0018	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—uterine cancer	0.000366	0.00178	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—uterine cancer	0.000354	0.00173	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—uterine cancer	0.000353	0.00172	CcSEcCtD
Hydrocodone—Dizziness—Etoposide—uterine cancer	0.000353	0.00172	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—uterine cancer	0.000352	0.00172	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000351	0.00171	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—uterine cancer	0.000341	0.00166	CcSEcCtD
Hydrocodone—Vomiting—Etoposide—uterine cancer	0.000339	0.00165	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—uterine cancer	0.000339	0.00165	CcSEcCtD
Hydrocodone—Rash—Etoposide—uterine cancer	0.000336	0.00164	CcSEcCtD
Hydrocodone—Dermatitis—Etoposide—uterine cancer	0.000336	0.00164	CcSEcCtD
Hydrocodone—Headache—Etoposide—uterine cancer	0.000334	0.00163	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—uterine cancer	0.000328	0.0016	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—uterine cancer	0.000326	0.00159	CcSEcCtD
Hydrocodone—Cough—Epirubicin—uterine cancer	0.00032	0.00156	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—uterine cancer	0.000317	0.00155	CcSEcCtD
Hydrocodone—Nausea—Etoposide—uterine cancer	0.000317	0.00154	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—uterine cancer	0.000312	0.00152	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—uterine cancer	0.000312	0.00152	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—uterine cancer	0.000311	0.00151	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00031	0.00151	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—uterine cancer	0.000305	0.00149	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—uterine cancer	0.000296	0.00144	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—uterine cancer	0.000294	0.00143	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—uterine cancer	0.000293	0.00143	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—uterine cancer	0.000293	0.00143	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—uterine cancer	0.00029	0.00141	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—uterine cancer	0.000289	0.00141	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—uterine cancer	0.000288	0.00141	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—uterine cancer	0.000288	0.00141	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—uterine cancer	0.000287	0.0014	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000286	0.0014	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—uterine cancer	0.000282	0.00137	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—uterine cancer	0.000279	0.00136	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000272	0.00133	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—uterine cancer	0.000271	0.00132	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—uterine cancer	0.000271	0.00132	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—uterine cancer	0.00027	0.00132	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—uterine cancer	0.000269	0.00131	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—uterine cancer	0.000268	0.00131	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—uterine cancer	0.000267	0.0013	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—uterine cancer	0.000266	0.0013	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—uterine cancer	0.000266	0.00129	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—uterine cancer	0.000258	0.00126	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000258	0.00126	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—uterine cancer	0.000258	0.00126	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—uterine cancer	0.000256	0.00125	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000252	0.00123	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—uterine cancer	0.00025	0.00122	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—uterine cancer	0.000248	0.00121	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—uterine cancer	0.000247	0.0012	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—uterine cancer	0.000246	0.0012	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000244	0.00119	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000239	0.00116	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—uterine cancer	0.000238	0.00116	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—uterine cancer	0.000236	0.00115	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—uterine cancer	0.000236	0.00115	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—uterine cancer	0.000236	0.00115	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000226	0.0011	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—uterine cancer	0.00022	0.00107	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—uterine cancer	0.000219	0.00107	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—uterine cancer	0.000219	0.00107	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—uterine cancer	0.000214	0.00104	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—uterine cancer	0.000211	0.00103	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—uterine cancer	0.000204	0.000993	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—uterine cancer	0.000198	0.000967	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—uterine cancer	0.000198	0.000963	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—uterine cancer	0.000196	0.000953	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—uterine cancer	0.00019	0.000926	CcSEcCtD
Hydrocodone—Rash—Epirubicin—uterine cancer	0.000188	0.000918	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—uterine cancer	0.000188	0.000917	CcSEcCtD
Hydrocodone—Headache—Epirubicin—uterine cancer	0.000187	0.000912	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—uterine cancer	0.000183	0.000891	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—uterine cancer	0.000177	0.000865	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—uterine cancer	0.000176	0.000857	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—uterine cancer	0.000174	0.00085	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—uterine cancer	0.000174	0.000849	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—uterine cancer	0.000173	0.000844	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—uterine cancer	0.000164	0.0008	CcSEcCtD
